|
September 22th, 2008
Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
Download the PDF
September 19th, 2008
Enobia Pharma receives FDA orphan drug designation for Hypophosphatasia product candidate ENB-0040
Download the PDF
September 15th, 2008
Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
Download the PDF
August 20th, 2008
Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
Download the PDF
Download the PDF (US)
September 10th, 2007
Enobia Pharma Raises $40.1M Series B Financing
Download the PDF
July 25, 2007
Enobia Pharma announces an agreement with Laureate Pharma for the production of its fusion protein which Enobia is developing for the treatment of hypophophatasia
Download the PDF
July 2007
Enobia Pharma announces new data on its hypophosphatasia program to be presented September 19, 2007 at the Annual Meeting of the ASBMR in Hawaii
More |